Our Science

Our Science : Clinical APPROACH

FORMA's selection criteria strives toward early stage clinical development success

Together with our strategic partners, we develop insights on clinical trial design and patient selection criteria in areas of great medical need. These insights inform our preclinical development strategies and guide our decisions for target selection, cell line development, and in vivo models. We prioritize drug target candidates that have qualified cellular mechanisms of action in specific diseases and specific patient populations, which enables us to look for early evidence of response in clinical development and thus lead to a rapid stream-lined path toward regulatory approval.